Tuberculosis News Media Resources
Progress Toward Tuberculosis Elimination Has Slowed in Recent Years – March 25, 2021
Although TB cases have fallen steadily since 1993, progress toward elimination has recently slowed and the COVID-19 pandemic has further strained TB prevention and control services.
51st Union World Conference – October 20-24, 2020
CDC and partners will present results from Study 31/A5349 – a landmark TB trial identifying a shorter-course treatment regimen – at the 51st Union World Conference on Lung Health. The conference will be held virtually from October 20-24, 2020 and feature new science and research on lung health topics.
Updated Recommendations for TB Screening, Testing and Treatment of U.S. Health Care Personnel – May 16, 2019
Historically, U.S. health care personnel were at increased risk for latent TB infection (LTBI) and TB disease from occupational exposures, but recent data suggest that this is no longer the case. CDC and the National Tuberculosis Controllers Association have updated the 2005 CDC recommendations for health care personnel.
CDC released updated recommendations for use of once-weekly isoniazid-rifapentine for 12 weeks (3HP) for treatment of latent TB infection. The updated recommendations support expanded use of an effective, shorter, treatment regimen to reach even more people with latent TB infection.
Tuberculosis continues to decline in the U.S., but progress toward elimination is slowing – March 22, 2018
Preliminary 2017 data, released today in advance of World TB Day, show that while TB case counts reached a record low in 2017, the rate of decline is too slow to eliminate TB during this century.
- In 2019, a total of 8,920 cases of TB disease were reported, a 1.1% decrease from 2018.
- TB continues to occur in every state and region in the U.S. with a 2019 incidence rate of 2.7 new cases per 100,000 people.
- The nation’s TB elimination goal is less than one case per million people. Currently, there are 27 cases per million people in the U.S.
Philip LoBue, MD, FACP, FCCP
Director, Division of Tuberculosis Elimination
View Dr. LoBue's full bio